{"result": {"id": "chatcmpl-287", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Hepatocellular Carcinoma Research Community\",\n    \"summary\": \"This community focuses on research related to hepatocellular carcinoma (HCC). Key entities include researchers, pharmaceutical companies, and patients. The community's structure revolves around the development of new treatments for HCC, with a focus on understanding the disease's biology and developing targeted therapies.  The community is characterized by collaboration between academic institutions, clinical trials, and industry partners. \",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The community exhibits high impact due to its direct contribution to medical research and treatment development for a significant disease like HCC.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant Research Focus on HCC Treatment\",\n            \"explanation\": \"The community's core focus is on developing new treatments for HCC. This includes investigating novel therapies, exploring targeted drug delivery systems, and understanding the molecular mechanisms driving tumor growth.  Research efforts are driven by a combination of academic institutions, clinical trials, and pharmaceutical companies. The community actively collaborates to accelerate progress in this field. \",\n            \"data\": [\n                \"425: DIET-DERIVED ANGIOGENESIS INHIBITORS,BIOACTIVITY,Diet-derived compounds can impact the bioactivity of angiogenesis inhibitors,5\", \n                \"430: DIET-DERIVED ANGIOGENESIS INHIBITORS,BIOAVAILABILITY,Diet-derived compounds can impact the bioavailability of angiogenesis inhibitors,7\"\n            ]\n        },\n        {\n            \"summary\": \"Collaboration is Key to Progress\",\n            \"explanation\": \"The community thrives on collaboration.  Academic researchers work closely with clinical trial organizations and pharmaceutical companies to translate research findings into real-world applications. This collaborative approach ensures that new treatments are developed and tested in a rigorous and efficient manner.\",\n            \"data\": [\n                \"429: DIET-DERIVED ANGIOGENESIS INHIBITORS,BIOACTIVITY,Diet-derived compounds can impact the bioactivity of angiogenesis inhibitors,5\", \n                \"31: P VALUE,TRIPLE THERAPY GROUP,The triple therapy group had a p-value of 0.04,5\"\n            ]\n        },\n        {\n            \"summary\": \"HAIC's Role in HCC Research and Treatment\",\n            \"explanation\": \"The HAIC (Hepatocellular Carcinoma Institute) plays a significant role in the community by providing resources for research, clinical trials, and patient support.  Their expertise in HCC treatment and their commitment to innovation make them a valuable partner for researchers and patients alike.\",\n            \"data\": [\n                \"26: HAIC,SORAFENIB,HAIC and sorafenib were found to be effective treatments for HCC,8\", \n                \"1747: SU4312,LENVATINIB,regorafenib,6\"\n            ]\n        },\n        {\n            \"summary\": \"The Impact of Diet on HCC Research\",\n            \"explanation\": \"Diet plays a crucial role in the development and progression of HCC.  Researchers are investigating the impact of specific dietary components on tumor growth and metastasis. This research aims to develop personalized dietary interventions for HCC patients, potentially improving treatment outcomes.\",\n            \"data\": [\n                \"425: DIET-DERIVED ANGIOGENESIS INHIBITORS,BIOACTIVITY,Diet-derived compounds can impact the bioactivity of angiogenesis inhibitors,5\", \n                \"431: DIET-DERIVED ANGIOGENESIS PROMOTERS,BIOACTIVITY,Diet-derived compounds can impact the bioactivity of angiogenesis promoters,5\"\n            ]\n        },\n        {\n            \"summary\": \"The Role of Clinical Trials in HCC Research\",\n            \"explanation\": \"Clinical trials are essential for evaluating the safety and efficacy of new treatments for HCC.  These trials involve carefully designed studies that recruit patients with HCC to test the effectiveness of different therapies. The community's focus on clinical trials ensures that new treatments are rigorously tested before being made available to patients.\",\n            \"data\": [\n                \"1072: SU4312,LENVATINIB,regorafenib,6\", \n                \"1917: MACES,ANGIOGENESIS INHIBITORS,Angiogenesis inhibitors are associated with increased risks of MACEs,8\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288285, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 937, "prompt_tokens": 2048, "total_tokens": 2985, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n126,ANGIOGENESIS INHIBITORS,\"**Angiogenesis inhibitors** are chemicals that prevent the growth of new blood vessels. These drugs work by blocking the process of angiogenesis, which is essential for tumor growth and spread. They are commonly used in conjunction with **HAIC (Hepatic Artery Interruption Chemotherapy)** for treating **uHCC (Unresectable Hepatocellular Carcinoma)**. \n\",7\n1241,BIOAVAILABILITY,\"\nThe amount of a compound that can be absorbed and used by the body\",4\n2708,PHOSPHATIDYLSERINES,,3\n2707,METHOXETREXATE,Known teratogen,5\n2705,ROTENONE,A drug,5\n137,SORAFENIB,A drug used in the treatment of HCC,5\n138,P VALUE,,4\n1238,ONCOLOGY,\"The **oncology** research field is dedicated to studying cancer, encompassing both its causes and potential treatments.  It involves investigating the mechanisms behind cancer development, progression, and treatment response. \n\",2\n2709,RETENONE,,2\n127,HAIC,\"The **HAIC** company is involved in developing drugs for the treatment of cancer, specifically focusing on liver cancer (HCC).  Their treatments are designed to address HCC and offer a comprehensive approach to managing the disease. \n\",3\n2706,ZFES,Embryos used in the study,3\n4545,MACES,\"**MACES** (Macular Edema Cases) are a specific type of event associated with the use of angiogenesis inhibitors.  These cases are often observed when individuals are treated with these medications, as their risk for macular edema increases. \n\",1\n1235,ONCOLOGICAL RESEARCH,Research on cancer,4\n1236,DIET-DERIVED ANGIOGENESIS INHIBITORS,\"Diet-derived compounds that inhibit angiogenesis\nDiet-derived compounds can impact the bioactivity of angiogenesis inhibitors\",3\n1239,ANGIOGENESIS PROMOTERS,Chemicals that promote angiogenesis,3\n2704,MEHTREXATE,A drug,2\n2710,ENERGY METABOLISM,,2\n2703,SU4312,A drug,1\n4085,LENVATINIB,Oral tyrosine kinase inhibitor,1\n140,TRIPLE THERAPY GROUP,,1\n1240,BIOACTIVITY,\"\nThe effect of a compound on the biological activity of another compound\",2\n1237,DIET-DERIVED ANGIOGENESIS PROMOTERS,\"Diet-derived compounds can impact the bioactivity of angiogenesis promoters\nDiet-derived compounds that promote angiogenesis\",3\n139,PSM,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n435,ANGIOGENESIS INHIBITORS,BIOAVAILABILITY,Diet-derived compounds can impact the bioavailability of angiogenesis inhibitors,11\n1077,ANGIOGENESIS INHIBITORS,PHOSPHATIDYLSERINES,Potential link to antiangiogenesis,10\n1079,METHOXETREXATE,ROTENONE,Methotrexate and rotenone show joint effects,10\n29,SORAFENIB,P VALUE,The sorafenib drug had a p-value of 0.04,9\n433,ONCOLOGY,ANGIOGENESIS INHIBITORS,Angiogenesis inhibitors are used in cancer treatment,9\n1078,ANGIOGENESIS INHIBITORS,RETENONE,Angiogenesis inhibitors and rotenone show joint effects,9\n26,HAIC,SORAFENIB,HAIC and sorafenib were found to be effective treatments for HCC,8\n1072,SORAFENIB,ZFES,The study used ZFEs to test the effects of sorafenib on embryonic development,8\n1075,ROTENONE,ZFES,The study used ZFEs to test the effects of rotenone on embryonic development,8\n1917,MACES,ANGIOGENESIS INHIBITORS,Angiogenesis inhibitors are associated with increased risks of MACEs,8\n425,ONCOLOGICAL RESEARCH,DIET-DERIVED ANGIOGENESIS INHIBITORS,Diet-derived compounds can bias oncological research of angiogenesis inhibitors,7\n430,DIET-DERIVED ANGIOGENESIS INHIBITORS,BIOAVAILABILITY,Diet-derived compounds can impact the bioavailability of angiogenesis inhibitors,7\n436,ANGIOGENESIS PROMOTERS,BIOAVAILABILITY,Diet-derived compounds can impact the bioavailability of angiogenesis promoters,7\n1073,MEHTREXATE,ROTENONE,Methotrexate and rotenone are developmental toxicants,7\n1082,METHOXETREXATE,ENERGY METABOLISM,Methotrexate may disrupt energy metabolism,7\n1071,SU4312,SORAFENIB,SU4312 and sorafenib are antiangiogenic drugs,6\n1747,SORAFENIB,LENVATINIB,regorafenib,6\n31,P VALUE,TRIPLE THERAPY GROUP,The triple therapy group had a p-value of 0.04,5\n429,DIET-DERIVED ANGIOGENESIS INHIBITORS,BIOACTIVITY,Diet-derived compounds can impact the bioactivity of angiogenesis inhibitors,5\n431,DIET-DERIVED ANGIOGENESIS PROMOTERS,BIOACTIVITY,Diet-derived compounds can impact the bioactivity of angiogenesis promoters,5\n28,HAIC,PSM,\"After PSM, the HAIC treatment regimen was used for HCC patients\",4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_7a24332ba2f7bd60b9ddc3296f9fa70fe531dc9d20182bc532746df1fc04db60_v2"}